medcelerator
Subscribe

Condition

Parkinson’s Disease

Treatments and trials tagged Parkinson’s Disease. Filter by country, access level, or patient stories.
All latest →
All countriesUnited StatesCanadaUnited KingdomJapanChinaAustraliaSwitzerlandEuropean UnionNewestPatient Stories
FDA ApprovedUnited States

Once-Daily Pill for Adults with Parkinson’s Disease

Juvmo (tavapadon) — selective D1/D5 dopamine agonist for Parkinson’s disease in adults

FDA approved 25 Sep 2026; Novel #43; first selective oral D1/D5 agonist; TEMPO program

This is for adults with Parkinson’s disease — and caregivers — who need a labelled once-daily oral option that can be used with or without levodopa.